Washington University researchers have received a $10.3 million grant renewal to continue a long-term study of adults who are more susceptible to developing Alzheimer’s because their parents had it. The team is trying to define which of these adults is likely to develop the disease — and when — and to…
The Alzheimer’s Foundation of America (AFA) will soon launch its 2018 “Educating America” tour to bring educational conferences on Alzheimer’s disease to patients, caregivers and the general public nationwide. The tour will visit 14 states — nine of which already have confirmed dates — to raise awareness, promote…
Takeda Pharmaceutical Company and Denali Therapeutics are teaming up to develop three treatments for Alzheimer’s disease and other neurodegenerative diseases. They will use Denali’s Antibody Transport Vehicle technology to get the therapies past the blood-brain barrier so they are able to work where they are needed — in the…
Servier and Treventis will work together on therapies that can circumvent the misfolded proteins involved in Alzheimer’s and other neurodegenerative diseases. The goal is to develop compounds that prevent the brain’s accumulation of two faulty proteins associated with the disorders — amyloid beta and tau. Servier is an international pharmaceutical concern led…
Four ways of possibly preventing dementia late in life — prescription medicines, over-the-counter (OTC) supplements and vitamins, physical activity, and cognitive training — are all seem to be inadequate at that task, a Minnesota Evidence-based Practice Center (EPC) study showed. Researchers conducted a systematic review of published to determine if…
Aricept (donepezil hydrochloride) is now approved in China to treat patients with severe Alzheimer’s disease, as well as those with mild or moderate disease, Eisai recently announced. The extended approval was based on the results of a Phase 3 clinical trial (NCT01404169) conducted in that country. The study was…
Marriage appears to be a strong and favorable factor in a person’s risk of developing dementia, with evidence suggesting that married people are at considerably lower risk than people who never marry or those who have lost a partner. The study, “Marriage and risk of dementia: systematic review…
Canadian researchers have developed a simple tool to track cognitive performance, so doctors can identify those at higher risk of developing Alzheimer’s or other forms of dementia. QuoCo consists of charts that show what a healthy person’s cognitive performance ought to be. It takes into account the person’s age,…
Probiodrug and Crossbeta Biosciences are extending a partnership that Probiodrug believes will help it continue developing a potential Alzheimer’s therapy. Under the partnership, established in 2016, the companies are using a proprietary Crossbeta technology to try to create biomarkers specific to Alzheimer’s as opposed to neurodegenerative diseases in general.
The number of Americans with Alzheimer’s disease or mild cognitive impairment, which can be a precursor to the disease, will more than double to 15 million by 2060, according to a new UCLA Fielding School of Public Health study. With funding from the…
Get regular updates to your inbox.